ALK2 plays an important role in the expression of hepcidin due to inflammatory cytokines and recent studies have focused on pharmacologically inhibiting this pathway.[25, 26] Future assessment of these alternative erythropoietic pathways may provide a more complete understanding of both anemia of chronic disease and anemia of unknown etiology. The gene discussed is HAMP; the disease is anemia.